Synthesize
4 known investors
Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design. The company helps biotech and pharmaceutical development teams de-risk trials, identify biomarkers, and extend early-phase data by generating synthetic patient cohorts.
AI & Machine LearningBiotechDigital Health
Founders & leadership
Investors · 4
Competitors · 4
by search overlap
Recursion (NASDAQ: RXRX)12 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Genomeweb10 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Twist Bioscience10 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
Engage Bio10 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Companies competing with Synthesize for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Synthesize do?
- Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design. The company helps biotech and pharmaceutical development teams de-risk trials, identify biomarkers, and extend early-phase data by generating synthetic patient cohorts.
- Who founded Synthesize?
- Synthesize was founded by Robert Bradley, PhD, Jeff Leek, PhD.
- Who are Synthesize's investors?
- Synthesize's investors include Madrona Venture Group, AI2 Incubator, Inner Loop Capital, Sahsen Ventures.